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ABSTRACT
Background: Canine transmissible venereal tumor (CTVT) is a peculiar neoplasm resulting from the transmission of host 
cancerous cells to another canid by implantation. Transmission occurs among reproductive age dogs, especially those 
with unrestricted sexual activity. It usually occurs on the external genitalia of dogs and other areas are unusual. However, 
implants have been described in injured mucosa, as well as metastases in lymph nodes, spleen, skin, anus and perianal 
space, oral mucosa, nasal mucosa, eyeball and brain. The purpose of this report is to describe the first case of exclusively 
extragenital ocular CTVT in a prepubescent female dog.
Case: A 6-month-old mixed-breed, non-spayed and prepubescent female dog, showing a fast-growing reddish-colored 
mass in the right eye (RE), was examined. Blepharospasm, mild serosanguineous secretion, chemosis and a smooth surface 
reddish mass with 2.5 cm in length occupying the orbital area were observed during physical examination, impairing the 
visualization of the right eyeball. For ocular ultrasonography examination of the affected eye, acepromazine was used (0.03 
mg/kg) associated with methadone (0.3 mg/kg) intramuscularly, and propofol (4 mg/kg) for induction and 0.2 mg/kg for 
maintenance, intravenously. Ultrasonography examination evidenced an amorphous hyperechogenic structure, medial to 
the RE, with homogeneous echotexture, punctiform vascularization to amplitude Doppler (Power Doppler), measuring 2.8 
cm in length and 1.4 cm in diameter, causing eyeball distortion and rejection. Based on ultrasonography results and with 
the patient still anesthetized, an incisional biopsy of the peribulbar mass was performed with a 5 mm disposable punch. 
The final CTVT diagnosis was possible after histopathological analysis.  No more CTVT nodules were found, especially 
in the vulva, which had a prepubescent appearance, consistent with age. Treatment with 4 sessions of chemotherapy with 
vincristine sulfate resulted in complete remission of the tumor mass. In the second session, it was already possible to 
visualize the eyeball with a significant remission of the tumor mass, ruling out neoplastic exceresis. At this time, threat 
response, normal direct and consensual photopupillary reflexes, normal eyelid reflex, corneal surface without slit lamp 
biomicroscopy and fluorescein staining were present in the RE. Nevertheless, there were mild diffuse corneal edema and 
slight ciliary injection. One percent prednisolone eye drops (8/8 h) and tobramycin eye drops (6/6 h) were prescribed for 
1 week. In the fourth session of chemotherapy, no changes were observed in the RE.
Discussion: In the present case, the diagnosis of CPVD in a prepubertal patient, primary orbital TVTV, and the fact that 
the structure of the eye bulb and visual function remain intact, even with the significant volume of orbital neoplasia, are 
highlighted. A single report of skin CTVT in an 11-month-old prepubescent female dog was found. It is important to 
emphasize that CTVT is typically of dogs of reproductive age that have genital masses. Usually, extragenital masses are 
related to the act of licking, scratching, biting or sniffing the primary tumor (self-implantation), or rarely, by metastasis, a 
fact not observed in the present report, since the ocular mass was the only manifestation. Treatment was conducted accord-
ing to indications of the literature. Four injections of vincristine sulfate were necessary, observing complete remission of 
the tumor mass with no relapse after 30 days. In this case report, it was possible to observe that CTVT may reveal unusual 
behaviors regarding epidemiology, which, added to the rare form of exclusively extragenital ocular clinical manifestation, 
impose a diagnostic challenge, making the histopathological examination an important tool for diagnosis.
Keywords: dog, eye, extragenital, Sticker’s Tumor.
2                                                                                                           A.V.C. Amaral, F. Mucha, I.B. Oliveira, et al. 2020. Primary Ocular Transmissible Venereal Tumor in a Prepubescent Female Dog.  
                                                                                                                 Acta Scientiae Veterinariae. 48(Suppl 1): 476.
INTRODUCTION
The canine transmissible venereal tumor 
(CTVT) is a peculiar neoplasm resulting from the 
transmission of cancerous cells of the host to another 
canid by implantation process [34]. Transmission occurs 
among reproductive age dogs, especially those with 
unrestricted sexual activity and access to the streets, by 
cell implantation during coitus, licking or interaction 
between the infected animal and the susceptible host 
[7,29,31]. It usually occurs on the external genitalia of 
male and female dogs and cases not affecting the genital 
area are unusual. However, implantation in extragenital 
areas, especially on injured mucosa, and metastases were 
described in spleen [5], skin [1], nasal mucosa [14,22], 
eyeball [3,5,21], brain [11], lymph nodes, anus and 
perianal space, oral mucosa, among other sites [16,28].
CTVT can be classified as evidencing a plas-
macytoid aspect when at least 70% of neoplastic cells are 
ovoid with lower nucleus : cytoplasm ratio and eccentric 
nucleus, as lymphocytic aspect when at least 70% of 
tumor cells resemble lymphocytes (round) with higher 
nucleus : cytoplasm ratio and round and central nucleus 
or even as lymphoplasmacytic or mixed aspect [2,20].
The most cited treatment is chemotherapy 
with vincristine sulfate [6,17,24,27,32]. However, 
depending on the extent and size of tumor, affected 
area, relapses or therapeutic failure, a combination 
of chemotherapeutic agents [4,15], surgical excision 
[24], electrochemotherapy [23] or immunomodulators 
[9,26,30] can be used.
The purpose of this report is to describe the 
first case of exclusively extragenital ocular CTVT in 
a prepubescent female dog.
CASE
A 6-month-old mixed-breed, non-spayed and 
prepubescent female dog was examined at the Jataí 
Regional Campus of the Federal University of Goiás 
with a history of a fast-growing reddish-colored mass in 
the right eye (RE). According to the guardian, the mass 
had initially emerged as a small structure in the nasal 
corner of the RE palpebral fissure and, over the course 
of two weeks, it quickly occupied the entire orbital area.
A complete ophthalmic examination was per-
formed in the left eye (LE), including threat response, 
eyelid reflex, direct photopupillary reflex, tear produc-
tion rate, tonometry, direct ophthalmoscopy and slit 
lamp biomicroscopy, with no abnormality observed.
Blepharospasm, mild serosanguineous secre-
tion, chemosis and a smooth surface reddish mass 
measuring approximately 2.5 cm in length occupy-
ing a large portion of the orbital area were observed 
during physical examination of the RE, impairing the 
visualization of the right eyeball. At the center of the 
mass, there was a grayish coloration area measuring 
approximately 8 mm in length.
As patient showed discomfort when the RE was 
manipulated for ocular ultrasonography examination, 
acepromazine (Acepran® 0.2%)1 was applied at a dose 
of 0.03 mg/kg associated with methadone (Mytedom®)2 
at a dose of 0.3 mg/kg intramuscularly as well as propo-
fol (Provive®)3 at a dose of 4 mg/kg for induction and 
0.2 mg/kg intravenously for maintenance.
Ultrasonography examination evidenced an 
amorphous hyperechogenic structure, medial to the 
RE, with homogeneous echotexture, punctiform vas-
cularization to amplitude Doppler (Power Doppler, 
SonoAce R3®)4, measuring about 2.8 cm in length 
and 1.4 cm in diameter, causing eyeball distortion and 
rejection (Figure 1).
In view of the ultrasonography examination 
results and with the patient still anesthetized, an inci-
sional biopsy of the peribulbar mass was performed 
with a 5 mm disposable punch. The sample was stored 
in a vial containing 10% buffered formaldehyde solu-
tion and submitted for routine histopathological evalua-
tion. A complete blood count and a biochemical profile 
were also evaluated, indicating only mild eosinophilia.
Tramadol (Dorless®)5 was prescribed at a 
dose of 4 mg/kg every 12 h, orally, for 1 week, and 
the Elizabethan collar and local cleansing with saline 
solution and gauze were indicated until the results of 
the histopathological examination.
Histopathological examination of the mass bi-
opsy revealed hypercellularity, with round to ovoid cells, 
moderate eosinophilic cytoplasm, predominantly ec-
centric nuclei and high mitotic level with predominantly 
plasmacytoid aspect (Figure 2), establishing the CTVT 
diagnosis according to the literature described [2,20].
In view of the histopathological examination 
results, which occurred ten days after the initial ap-
pointment, the patient was referred for chemotherapy 
treatment with vincristine sulfate (Tecnocris®)6 at a 
dose of 0.03 mg/kg. It was observed that the mass had 
grown expressively in the ocular orbit, showing reddish 
coloration, friable aspect, necrosis areas, sanguineous 
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secretion and foul odor characteristic of CTVT. The 
evolution of the tumor mass in 10 days can be observed 
in Figure 3.
At the time, a new physical examination was 
performed in the patient to inspect and search for pos-
sible CTVT nodules, especially on the vulva, however 
only evidencing the organ with prepubescent aspect, 
consistent with the age. Submandibular, pre-scapular 
and popliteal lymph nodes showed no volume altera-
tions on palpation. Vaginal cytology was performed 
searching for neoplastic cells on slides stained with 
fast panoptic. The results of the samples analyzed 
were negative.
The chemotherapeutic protocol consisted of 
four vincristine sulfate applications at the dose de-
scribed, with seven-day interval between applications, 
by slow venous infusion with 0.9% NaCl solution7. 
Before each application, a blood sample for complete 
blood count and biochemical profile was collected in 
order to monitor possible complications to the che-
motherapy protocol, observing only lymphocytosis.
In the second session of chemotherapy, it was 
already possible to visualize the eyeball with a fairly 
significant remission of the tumor mass, discarding a 
possible surgical procedure for neoplasm excision as 
part of the treatment. However, a complete RE exami-
nation was not yet possible due to the presence of the 
mass, though the presence of threat response, normal 
direct and consensual photopupillary reflexes, normal 
eyelid reflex, corneal surface with no ulceration at slit 
lamp biomicroscopy and fluorescein staining were 
observed in the RE, nevertheless with mild diffuse 
corneal edema and slight ciliary injection. Prednisolone 
eye drops (Predfort®)8 every 8 h and tobramycin eye 
drops (Tobrex®)9 every 6 h were prescribed for 1 week.
In the fourth session of chemotherapy, a com-
plete ophthalmic examination of the RE and LE was 
performed, and no changes were observed. At the 
time, a sample was collected for conjunctival cytology 
to search for neoplastic cells on slides stained with 
fast panoptic. No neoplastic cells were found in the 
samples. The clinical aspect of tumor mass involution 
can be observed in Figure 4.
The patient was examined again 30 days after 
the fourth session of chemotherapy and no signs of 
tumor growth were observed.
DISCUSSION
Some noteworthy specificities of this case report 
are the diagnosis of CTVT in a prepubescent patient, 
the primary orbital CTVT and the fact that the ocular 
bulb structure and the visual function remained intact, 
even with the expressive volume of orbital neoplasm.
A single report of CTVT in an 11-month-
-old prepubescent female dog manifested on the skin 
was found [19]. Similarly to the findings of this case 
report, that study by Marcos et al. [19] was an exclu-
sive extragenital (cutaneous) occurrence, justifying 
social interaction and not sexual behavior for tumor 
transmission. However, this case report is the first to 
describe an exclusively extragenital ocular CTVT in 
a prepubescent female dog.
Figure 1. Presence of an amorphous hyperechogenic structure (arrow), medial to the right eye, with homogeneous echotexture, measuring about 2.8 cm 
in length and 1.4 cm in diameter, causing eyeball distortion.
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It is believed that social interaction occurred 
with infected street dogs, although the guardian stated 
that the patient did not have access to the streets and 
considering that other contacting dogs in the same 
house did not have the disease. It is suspected that 
contact with an infected street dog occurred through 
the residential gate, since the guardian reported the 
presence of wandering dogs nearby.
It is important to emphasize that CTVT typi-
cally affects reproductive age dogs and its main clinical 
manifestation is the presence of genital masses. Com-
monly, the presence of extragenital masses is related to 
the act of licking, scratching, biting or sniffing the pri-
mary areas affected by the tumor (self-implantation), 
or rarely by metastasis [8,16,18,25]. However, these 
were not the hypotheses for the case, since the ocular 
mass was the only manifestation.
There was exuberant growth of the tumor mass 
ten days after the first appointment. The diagnosis 
delay may be justified by the unusual manifestation 
of CTVT [10,30]. Otherwise, the chemotherapeutic 
Figure 2. Six-month-old mixed-breed female dog. Macro and microscopic 
images of orbital mass biopsy. A- Microscopic image showing hyper-
cellularity with well-delimited contour cells infiltrating between delicate 
dermal collagen fibers (arrowhead) and abundant blood vessels (v) [HE 
100x; Bar= 100 μm]. B- Same sample in greater detail, showing relatively 
uniform round to ovoid cells, arranged in the form of lines and “ropes”. 
Vascularization (v) is preserved [HE 200x; Bar= 50 μm]. C- Greater mi-
croscopic detailing of sample showing cells with moderate eosinophilic 
cytoplasm, predominantly eccentric nuclei and high mitotic level (arrows) 
[HE 400x; Bar= 20 μm]. (*) epidermis.
Figure 3. Six-month-old mixed-breed female dog with ocular CTVT 
diagnosis prior to the start of chemotherapy. A- Reddish coloration mass 
filling the right orbit, with apparent necrosis area (white arrow), at the time 
of the first physical examination. B- Mass evolution in 10 days, revealing 
expressive growth in the ocular orbit, reddish coloration, friable aspect, 
necrosis areas and sanguineous secretion.
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protocol could have been started on the same day of 
the first appointment, avoiding the patient suffering 
and guardian’s anguish.
Treatment was conducted according to indica-
tions of the literature [33]. Four injections of vincristine 
sulfate were necessary, observing complete remission 
of the tumor mass with no relapse after 30 days. In the 
study conducted by Paranzini et al. [24], the 6.27 ± 1.82 
mean of vincristine sulfate applications was found, 
with a minimum of one and a maximum of eleven 
sessions of chemotherapy. The authors reported that 
the need for more than four doses of chemotherapy or 
combination of protocols was common for the remis-
sion of tumor masses of CTVT. However, this was not 
observed in our case report, which showed excellent 
response to vincristine, revealing significant remission 
shortly after the first application.
Resistance to chemotherapy with vincristi-
ne sulfate on CTVT could be found, especially in 
plasmacytoid tumors, where a higher expression of 
P-glycoprotein was observed [13]. However, in this 
case, the response to chemotherapy was effective.
Ocular lesions as the only manifestation of 
CTVT in 22 dogs were reported by Komnenou et al. 
[17], where most of the subjects were male dogs be-
tween 2 and 7 years old. According to the authors, the 
tumor masses were mainly on the bulbar conjunctiva of 
the nictitating membrane, similarly to the one observed 
in this case report, in which it was possible to notice 
the location of the mass more accurately during the 
second session of chemotherapy, in which it already 
showed remission, enabling a better inspection of 
ocular structures.
The most frequent occurrence of CTVT on the 
nictitating membrane and on the ocular structure was 
explained by the fact that this membrane constitutes 
a protection to the ocular bulb, that protrudes due to 
some aggression, being susceptible to being compro-
mised and injured during the sexual behavior of the 
dog sniffing and licking, allowing the inoculation of 
tumor cells [17]. It is believed that something similar 
occurred to the patient of our case report, with social 
rather than sexual behavior.
In the study by Komnenou et al. [17], deep 
ulcerative keratitis was observed in 32% of the dogs 
due to the presence of tumor mass in the palpebral 
conjunctiva or in the nictitating membrane. In our case 
report, no corneal ulcer was observed. It is believed 
that the absence of the corneal lesion occurred due to 
the short time of exposure of the ocular surface to the 
tumor mass or the absence of previous eye injury.
Figure 4. Six-month-old mixed-breed female dog with ocular CTVT 
diagnosis after the start of chemotherapy. A- Seven days after the first 
session of chemotherapy with vincristine sulfate. A pinkish coloration 
tumor mass in scleral and third eyelid conjunctives and mild to moderate 
diffuse corneal edema (white arrow). B- Seven days after the third session 
of chemotherapy, a small pinkish coloration mass in the conjunctiva (white 
arrow). C- Seven days after the fourth session of chemotherapy, with no 
signs of ocular mass.
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In this case report, it was possible to observe 
that CTVT may reveal unusual behaviors regarding 
epidemiology, which, added to the rare form of exclusi-
vely extragenital ocular clinical manifestation, impose 
a diagnostic challenge, making the histopathological 
examination an important tool for diagnosis.
MANUFACTURERS
1Vetnil-Indústria e Comércio de Produtos Veterinários Ltda. Louveira, 
SP, Brazil.
2Cristália Produtos Químicos Farmacêuticos Ltda. Itapira, SP, Brazil.
3União Química - Farmacêutica Nacional S/A. São Paulo, SP, Brazil.
4Samsung Medison. Seoul, South Korea.
5Agener-União Saúde Animal - Farmacêutica Nacional S/A. São 
Paulo, SP, Brazil.
6Zodiac Produtos Farmacêuticos S/A. Pindamonhangaba, SP, Brazil.
7Equiplex Indústria Farmacêutica. Anápolis, GO, Brazil.
8Allergan Brazil. Guarulhos, SP, Brazil.
9Novartis Biociências S/A. São Paulo, SP, Brazil.
Declaration of interest. The authors report no conflicts of 
interest. The authors alone are responsible for the content and 
writing of this paper.
REFERENCES
1 Albanese F., Poli A., Millanta F. & Abramo F. 2002. Primary cutaneous extragenital canine transmissible venereal 
tumour with Leishmania-laden neoplastic cells: a further suggestion of histiocytic origin? Veterinary Dermatology. 
13(5): 243-246.
2 Amaral A.S., Gaspar L.F.J., Silva S.B. & Rocha N.S. 2004. Diagnóstico citológico do tumor venéreo transmissível 
na região de Botucatu, Brasil (estudo descritivo: 1994-2003). Revista Portuguesa de Ciências Veterinárias. 99(551): 
167-171.
3 Amaral A.V.C., Oliveira R.F., Silva A.P.S.M., Baylão M.L., Luz L.C & Santana F.J.F. 2012. Tumor venéreo trans-
missível intra-ocular em cão: relato de caso. Veterinária e Zootecnia. 19: 79-85.
4 Amber E.I., Henderson R.A., Adeyanju J.B. & Gyang E.O. 1990. Single-Drug Chemotherapy of canine transmis-
sible venereal tumor with cyclophosphamide, methotrexate, or vincristine. Journal of Veterinary Internal Medicine. 
4(3): 144-147. 
5 Batista J.S., Soares H.S.S., Pereira R.H.M.A., Petri A.A., Sousa D.N.S. & Nunes F.C.R. 2007. Tumor venéreo 
transmissível canino com localização intra-ocular e metástase no baço. Acta Veterinaria Brasilica. 1(1): 45-48.
6 Chokeshaiusaha K., Puthier D., Nguyen C., Sudjaidee P. & Sananmuang T. 2019. Factor Analysis for Bicluster 
Acquisition (FABIA) revealed vincristine-sensitive transcript pattern of canine transmissible venereal tumors. Heliyon. 
5: 1-8.
7 Dabus D.M.M., Tentrin T.C., Bocardo M., Lima G.S., Lot R.F.E., Bariani M.E. & Rocha N.S. 2008. Estudo 
epidemiológico do tumor venéreo transmissível baseado nos padrões plasmocitóide e linfocitóide em cães atendidos 
no Hospital Veterinário da Faculdade de Medicina Veterinária e Zootecnia de Garça. Revista Científica Eletrônica de 
Medicina Veterinária. 11(1): 1-7.
8 Dass L.L., Sahay P.N., Kahn A.A. & Jha G.J. 1986. Malignant transmissible veneral tumor. Canine Practice. 13(3): 
15-18.
9 Den Otter W., Hack M., Jacobs J.J.L., Tan J.F.V., Rozendaal L. & Van Moorselaar R.J.A. 2015. Effective Treat-
ment of Transmissible Venereal Tumors in Dogs with Vincristine and IL2. Anticancer Research. 35: 3385-3392.
10 Duzanski A.P., Fêo H.B., Montoya L.M., Seullner C.V. & Rocha N.S. 2017. Canine   Transmissible Venereal Tumor: 
Is Its Biological Behavior Changing? The Anatomical Record. 300(6): 1009-1010.
11 Ferreira A.J.A., Jaggy A., Varejäo A.P., Ferreira M.L., Correia J.M., Mulas J.M., Almeida O., Oliveira P. & 
Prada J. 2000. Brain and ocular metastases from a transmissible venereal tumour in a dog. Journal of Small Animal 
Practice. 41(4): 165-168. 
12 Ganguly B., Das U. & Das A.K. 2013. Canine transmissible venereal tumour: a review. Veterinary and Comparative 
Oncology. 14(1): 1-12.
13 Gaspar L.F.J., Amaral A.S., Bassani-Silva S. & Rocha N.S. 2009. Imunorreatividade à glicoproteína-p no tumor 
venéreo transmissível canino. Veterinária em Foco. 6(2): 140-146.
14 Ginel P.J., Molleda J.M., Novales M., Martín E., Margarito J.M. & López R. 1995. Primary transmissible venereal 
tumor in the nasal cavity of a dog. The Veterinary Record. 136(9): 222-223.
7                                                                                                           A.V.C. Amaral, F. Mucha, I.B. Oliveira, et al. 2020. Primary Ocular Transmissible Venereal Tumor in a Prepubescent Female Dog.  
                                                                                                                 Acta Scientiae Veterinariae. 48(Suppl 1): 476.
CR476
http://seer.ufrgs.br/ActaScientiaeVeterinariae
15 Javanbakht J., Pedram B., Taheriyan M.R., Khadivar F., Hosseini S.H., Abdi F.S., Hosseini E., Moloudizargari 
H., Aghajanshakeri S.H., Javaherypour S., Shafiee R. & Emrani R. 2014. Canine transmissible venereal tumor 
and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression 
after chemotherapy. Tumor Biology. 35(6): 5493-5500.
16 Kabuusu R.M., Stroup D.F. & Fernandez C. 2010. Risk factors and characteristics of canine transmissible venereal 
tumors in Grenada, West Indies. Veterinary and Comparative Oncology. 8(1): 50-55.
17 Komnenou A.T., Thomas A.L.N., Kyriazis A.P., Poutahidis T. & Papazoglou L.G. 2015. Ocular manifestations of 
canine transmissible venereal tumour: a retrospective study of 25 cases in Greece. The Veterinary Record. 176(20): 1-5.
18 Lin S.C., Chuang T.F., Lin C.S., Lin D.S. & Liao A.T. 2014. Immune characterization of peripheral blood mono-
nuclear cells of the dogs restored from inoculation of canine transmissible venereal tumor cells. Taiwan Veterinary 
Journal. 40(4): 181-190.
19 Marcos R., Santos M., Marrinhas C. & Rocha E. 2006. Cutaneous transmissible venereal tumor without genital 
involvement in a prepubertal female dog. Veterinary Clinical Pathology. 35(1): 106-109. 
20 Meuten D.J. 2002. Tumors in Domestic Animals. 4th edn. Ames: Iowa State Press, 800p.
21 Milo J. & Snead E. 2014. A case of ocular canine transmissible venereal tumor. The Canadian Veterinary Journal. 
55(1): 1245-1249.
22 Ojeda J., Mieres M., Soto F., Arnes V., Paredes E. & Navarrete M. 2018. Computer tomographic imaging in 4 
dogs with primary nasal canine transmissible venereal tumor and differing cellular phenotype. Journal of Veterinary 
Internal Medicine. 32(3): 1172-1177. 
23 Osorio-Morales L.F & Pedraza-Ordóñez F. 2017. Electrochemotherapy Treatment of Canine Transmissible Venereal 
Tumors. Artificial Organs. 41(12): 1185-1185. 
24 Paranzini C.S., Sant’anna M.C., Santis G.W & Martins M.I.M. 2015. Prevalence of different cytomorphological 
types of transmissible venereal tumours and the association with prognosis in dogs treated with vincristine sulphate - 
Retrospective study. Semina: Ciências Agrárias. 36(6): 3795-3800.
25 Pereira J.S., Silva A.B., Martins A.L., Ferreira A.M. & Brooks D.E. 2000. Immunohistochemical characterization 
of intraocular metastasis of a canine transmissible venereal tumor. Veterinary Ophthalmology. 3(1): 43-47. 
26 Ramos-Zayas Y., Franco-Molina M.A., Hernádez-Granados A.J., Zárate-Triviño D.G., Coronado-Cerda E.E., 
Mendoza-Gamboa E., Zapata-Benavides P., Ramírez-Romero R., Santana-Krymskaya S.E., Tamez-Guerra 
R. & Rodríguez-Padilla C. 2018. Immunotherapy for the treatment of canine transmissible venereal tumor based in 
dendritic cells pulsed with tumoral exosomes. Immunopharmacology and Immunotoxicology. 41(1): 48-54. 
27 Raposo A.C.S., Gomes Junior D.C., Lima F.B., Araujo N.L.L.C. & Oriá A.P. 2014. Tumor venéreo transmissível 
primário em conjuntiva palpebral de cão: relato de casos. Enciclopédia Biosfera. 10(19): 1803-1809.
28 Sant’ana F.J.F., Lima T.F., Souza F.R., Rabelo R.E., Romani A.F. & Kunz T.L. 2004. Caracterização anatomopa-
tológica do Tumor Venéreo Transmissível em cães atendidos na Escola de Veterinária da UFG/CAJ. In: Resumos do 
XXXI Congresso Brasileiro de Medicina Veterinária (São Luis, Brasil). 1 CD-ROM.
29 Santos F.G.A., Vasconcelos A.C., Moro L., Nunes J.E.S. & Paixão T.A. 2001. Apoptose no tumor venéreo transmis-
sível canino: características morfológicas e evidenciação bioquímica. Arquivo Brasileiro de Medicina Veterinária e 
Zootecnia. 53(5): 557-562. 
30 Setthawongsin C., Tangkawattana S., Rungsipipat A. & Techangamsuwan S. 2019. In vitro Effect of Recombinant 
Feline Interferon-Ω (rFeIFN-Ω) on the Primary CanineTransmissible Venereal Tumor Culture. Frontier in Veterinary 
Science. 6(104): 1-7.
31 Tinucci-Costa M. 2008. Tumor Venéreo Transmissível Canino. In: Daleck C.R., Nardi A.B. & Rodaski S. (Eds). 
Oncologia em Cães e Gatos. São Paulo: Roca, pp.539-556.
32 Varughese E., Singla V., Ratnakaran U. & Gandotra V.K. 2012. Successful Management of Metastatic Transmis-
sible Venereal Tumour to Skin of Mammary Region. Reproduction in Domestic Animals. 47(6): 366-369. 
33 Viana F.A.B. 2019. Guia Terapêutico Veterinário. 4.ed. Lagoa Santa: Editora Cem, 528p.
34 Wang X., Zhou B., Yang M., Yin T., Chen F., Ommeh S., Esmailizadeh A., Turner M., Poyarkov A., 
Savolainen P., Wang G., Fu Q. & Zhang Y. 2019. Canine transmissible venereal tumor genome reveals 
ancient introgression from coyotes to pre-contact dogs in North America. Cell Research. 29: 1-4. 
